
Recent data suggest that zzso B virus zzso zzso develops in zzso of breast cancer zzso patients carrying zzso after zzso Our study aimed to determine the role of zzso use of zzso in BC patients undergoing zzso 

The test group consisted of 11 female patients with BC who were zzso for zzso B surface zzso zzso Of these, 10 patients were treated in an zzso setting and one for zzso zzso zzso was given from the start of chemotherapy and was maintained until 1 month after the last infusion of zzso The control group consisted of nine historical BC patients carrying zzso and received similar systemic chemotherapy without zzso zzso zzso including zzso zzso envelope zzso zzso envelope zzso serial serum zzso zzso zzso quantitative zzso viral DNA analysis, and zzso zzso promoter and zzso sequence were zzso Test for emergence of zzso zzso notably zzso zzso was performed 6 months after the completion of zzso 

All patients tolerated zzso well without development of evident zzso zzso or overt zzso zzso zzso remained unchanged without rebound zzso after zzso of chemotherapy and withdrawal of zzso No emergence of zzso resistant strain zzso zzso zzso was zzso 

Our results encourage zzso use of zzso for prevention of zzso zzso in patients who need short-term zzso 

